Evidence map›Paper›PMID 36417532›Full record

ArticleScience advances2022

The free fatty acid-binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron.

Christine Toelzer, Kapil Gupta, Sathish K N Yadav, Lorna Hodgson, Maia Kavanagh Williamson, Dora Buzas, Ufuk Borucu, Kyle Powers, Richard Stenner, Kate Vasileiou and 10 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. International journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Christine ToelzerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0001-9984-5940
Kapil GuptaSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-2115-3503
Sathish K N YadavSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0003-0779-0941
Lorna HodgsonSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0001-6373-4405
Maia Kavanagh WilliamsonCellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK.ORCID 0000-0002-4659-8613
Dora BuzasSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0003-3883-6340
Ufuk BorucuSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0001-6746-5409
Kyle PowersSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0003-3240-6534
Richard StennerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0003-0734-8686
Kate VasileiouSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-1878-4603
Frederic GarzoniImophoron Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK.ORCID 0000-0001-9668-9348
Daniel FitzgeraldHalo Therapeutics Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK.
Christine PayréUniversité Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne Sophia Antipolis, France.
Gunjan GautamSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0003-4353-6676
Gérard LambeauUniversité Côte d'Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne Sophia Antipolis, France.ORCID 0000-0002-9239-518X
Andrew D DavidsonCellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK.ORCID 0000-0002-1136-4008
Paul VerkadeSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-2497-1026
Martin FrankBiognos AB, Box 8963, 40274 Göteborg, Sweden.ORCID 0000-0002-1006-6746
Imre BergerSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0001-7518-9045
Christiane SchaffitzelSchool of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol BS8 1TD, UK.ORCID 0000-0002-1516-9760
At Bristol · GBCentre National de la Recherche Scientifique · FRPhilips (United Kingdom) · GBUniversity of Bristol · GBBiognos (Sweden) · SE

Funding

Medical Research Council MR/V027506/1Wellcome Trust
6 · The paper itself

Abstract

As coronavirus disease 2019 (COVID-19) persists, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) emerge, accumulating spike (S) glycoprotein mutations. S receptor binding domain (RBD) comprises a free fatty acid (FFA)-binding pocket. FFA binding stabilizes a locked S conformation, interfering with virus infectivity. We provide evidence that the pocket is conserved in pathogenic β-coronaviruses (β-CoVs) infecting humans. SARS-CoV, MERS-CoV, SARS-CoV-2, and VOCs bind the essential FFA linoleic acid (LA), while binding is abolished by one mutation in common cold-causing HCoV-HKU1. In the SARS-CoV S structure, LA stabilizes the locked conformation, while the open, infectious conformation is devoid of LA. Electron tomography of SARS-CoV-2-infected cells reveals that LA treatment inhibits viral replication, resulting in fewer deformed virions. Our results establish FFA binding as a hallmark of pathogenic β-CoV infection and replication, setting the stage for FFA-based antiviral strategies to overcome COVID-19.

Indexed as

COVID-19Spike Glycoprotein, CoronavirusFatty Acids, NonesterifiedHumansSARS-CoV-2Fatty Acids, NonesterifiedSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID36417532
PMCPMC9683698
OpenAlexW4310088512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.